醫療財團法人徐元智先生醫藥基金會亞東紀念醫院，簡稱亞東紀念醫院，是一所位於臺灣新北市板橋區的醫學中心等級的大型綜合醫院。

During the past decade, Far Eastern Memorial Hospital conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 19 clinical trials were completed, i.e. on average, 22.6% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 13 clinical trials were completed. i.e. 37.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Far Eastern Memorial Hospital" #1 sponsor was "Far Eastern Memorial Hospital" with 92 trials, followed by "National Taiwan University Hospital" with 13 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Far Eastern Memorial Hospital" #1 collaborator was "National Science Council, Taiwan" with 11 trials as a collaborator, "Far Eastern Memorial Hospital" with 7 trials as a collaborator, "National Taiwan University Hospital" with 5 trials as a collaborator, "Department of Health, Executive Yuan, R.O.C. (Taiwan)" with 4 trials as a collaborator and "Gynecologic Oncology Group" with 4 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Far Eastern Memorial Hospital" are "Coronary Artery Disease" (5 trials), "Diabetes Mellitus, Type 2" (5 trials), "Hepatitis C" (4 trials), "Chronic Hepatitis C" (3 trials) and "Fatty Liver" (3 trials). Many other conditions were trialed in "Far Eastern Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Far Eastern Memorial Hospital" are "Drug" (66 trials), "Other" (18 trials), "Procedure" (14 trials), "Biological" (9 trials) and "Device" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Filgotinib" (3 trials), "placebo" (3 trials), "Placebo to match filgotinib" (2 trials) and "Thallium-201 Myocardial Perfusion Study" (2 trials). Other intervention names were less common.

The vast majority of trials in "Far Eastern Memorial Hospital" are 141 trials for "All" genders and 22 trials for "Female" genders.

Currently, there are 35 active trials in "Far Eastern Memorial Hospital". 1 are not yet recruiting, 24 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 74 completed trials in Far Eastern Memorial Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Far Eastern Memorial Hospital, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 29 trials that are defined as “Not Applicable".